PATENT CLAIM ANALYSIS

Application Number: 15970540
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "269100"]

Abstract:
The present invention provides a method for treating canine leishmaniasis by immunotherapy.

Claim (Index 4):
The method of  claim 3  wherein the photosensitizer is cationic and soluble.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14169713', '13383952', '13794903', '13841949', '13296675']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6213783166622228
- 35 USC 102 Novelty (BERT): 0.4987303658887048
- Combined Prediction Score: 0.6091135215848711
- Mean Citation Score: 58.11930220000001
- Max Citation Score: 63.181587
- Similarity Product: 34.69680808012998

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test